Preet Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-12-2024
- Paid Up Capital ₹ 1.07 M
as on 15-12-2024
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.91 M
as on 15-12-2024
- Revenue 89.08%
(FY 2022)
- Profit 59.85%
(FY 2022)
- Ebitda 79.55%
(FY 2022)
- Net Worth -21.49%
(FY 2022)
- Total Assets -30.81%
(FY 2022)
About Preet Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.07 M.
The company has closed loans amounting to ₹8.91 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dhairya Sheth and Priti Sheth serve as directors at the Company.
- CIN/LLPIN
U24231GJ1992PTC018516
- Company No.
018516
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Preet Pharma Pvt Ltd offer?
Preet Pharma Pvt Ltd offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Cardiovascular Drugs & Medication, Diabetes Medicine, Muscle Relaxant, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Preet Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhairya Sheth  | Director | 03-Nov-1992 | Current |
| Priti Sheth | Director | 03-Nov-1992 | Current |
Financial Performance of Preet Pharma.
Preet Pharma Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 89.08% increase. The company also saw a substantial improvement in profitability, with a 59.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Preet Pharma?
In 2019, Preet Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 30 Mar 2009 | ₹2.75 M | Satisfied |
Bank Of India Creation Date: 29 Nov 2005 | ₹0.45 M | Satisfied |
Bank Of India Creation Date: 22 Sep 2005 | ₹4.06 M | Satisfied |
How Many Employees Work at Preet Pharma?
Unlock and access historical data on people associated with Preet Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Preet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Preet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
